Results of AGM

Thursday, 20 October 2022

Dechra® Pharmaceuticals PLC

Results of Annual General Meeting (AGM)

A poll was held on each of the resolutions proposed at the Annual General Meeting (AGM) of the Company held today

(20 October 2022). All resolutions were passed and are as follows:

Resolution (No. as noted on proxy form)

Total For (includes Discretionary)

Total Against

Total Cast (excludes Withheld)

Withheld (1)

No. of votes

% of vote

No. of votes

% of vote

No. of votes

% of vote

No. of votes

Ordinary Business:

Resolution 1:

To receive the accounts, the Strategic Report, the Directors' Report and the Auditor's Report

82,263,193

99.89%

90,162

0.11%

82,353,355

72.35

849,642

Resolution 2:

To approve the Directors' Remuneration Report

79,297,256

95.31%

3,901,808

4.69%

83,199,064

73.10

3,933

Resolution 3:

To declare a final dividend

83,199,118

100.00%

1,739

0.00%

83,200,857

73.10

2,140

Resolution 4:

To elect John Shipsey

82,225,331

98.83%

974,701

1.17%

83,200,032

73.10

2,965

Resolution 5:

To re-elect Alison Platt

70,534,490

93.25%

5,105,848

6.75%

75,640,338

66.46

7,562,659

Resolution 6:

To re-elect Ian Page

81,717,540

98.22%

1,480,147

1.78%

83,197,687

73.10

5,310

Resolution 7:

To re-elect Anthony Griffin

81,729,006

98.23%

1,471,081

1.77%

83,200,087

73.10

2,910

Resolution 8:

To re-elect Paul Sandland

81,598,155

98.07%

1,601,932

1.93%

83,200,087

73.10

2,910

Resolution 9:

To re-elect Lisa Bright

81,024,175

97.39%

2,174,336

2.61%

83,198,511

73.10

4,486

Resolution 10:

To re-elect Lawson Macartney

80,756,857

97.06%

2,443,175

2.94%

83,200,032

73.10

2,965

Resolution 11:

To re-elect Ishbel Macpherson

80,852,117

97.18%

2,346,393

2.82%

83,198,510

73.10

4,487

Resolution 12:

To re-appoint PricewaterhouseCoopers as external auditor of the company

82,422,445

99.08%

766,389

0.92%

83,188,834

73.09

14,163

Resolution 13:

To authorise the Audit Committee to determine the remuneration of the external auditor

83,082,125

99.86%

118,208

0.14%

83,200,333

73.10

2,664

Special Business:

Resolution 14:

To authorise the directors to allot shares to specific limits

75,904,608

91.23%

7,296,215

8.77%

83,200,823

73.10

2,174

Resolution 15:

To disapply the pre-emption rights

81,644,651

98.13%

1,552,203

1.87%

83,196,854

73.09

6,143

Resolution 16:

To disapply additional pre-emption rights

80,880,510

97.22%

2,316,443

2.78%

83,196,953

73.09

6,044

Resolution 17:

To authorise the Company to purchase its own shares

82,445,021

99.11%

737,441

0.89%

83,182,462

73.08

20,535

Resolution 18:

To authorise the Company to hold any general meeting (other than an AGM) on not less than 14 clear days' notice

78,978,217

94.92%

4,222,557

5.08%

83,200,774

73.10

2,223

Notes:

1. A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution.

2. Resolutions 1 to 14 were ordinary resolutions, requiring more than 50% of shareholder votes to be "For" the resolutions.

3. Resolutions 15 to 18 were special resolutions, requiring more than 75% of shareholder votes to be "For" the resolutions.

4. Issued Share Capital at meeting date: 113,820,672

5. Equiniti, Registrar to the Company, were appointed for the purpose of the Poll taken at the AGM and certify as scrutineer that the result of the Poll is correctly set out above.

In accordance with Listing Rule 9.6.2R, a copy of the resolutions passed as special business at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at the FCA document viewing facility https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

For further information, please contact:

Melanie Hall

Company Secretary

Dechra Pharmaceuticals PLC

Telephone: +44 (0) 1606 814 730

Email: corporate.enquiries@dechra.com

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. For more information, please visit: www.dechra.com.

Trademarks

Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Dechra Pharmaceuticals plc published this content on 20 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 October 2022 13:39:02 UTC.